Erratum: Early inflammatory reactions in atherosclerosis are induced by proline-rich tyrosine kinase/reactive oxygen species-mediated release of tumor necrosis factor-α and subsequent activation of the p21Cip1/Ets-1/p300 system. Arterioscler Thromb Vasc Biol. 2011;31:1084-1092; DOI: 10.1161/ATVBAHA.110.221804;Early inflammatory reactions in atherosclerosis are induced by proline-rich tyrosine kinase/reactive oxygen species-mediated release of tumor necrosis factor-α and subsequent activation of the p21Cip1/Ets-1/p300 system

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 31, Issue 5, 2011, Pages 1084-1092

  Katsume, Asako ^a   Okigaki, Mitsuhiko ^a   Matsui, Akihiro ^a   Che, Jishan ^a   Adachi, Yasushi ^b   Kishita, Eigo ^a   Yamaguchi, Shinichiro ^a   Ikeda, Koji ^a   Ueyama, Tomomi ^a   Matoba, Satoaki ^a   Yamada, Hiroyuki ^a   Matsubara, Hiroaki ^a  

^a KYOTO PREFECTURAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

atherosclerosis; cytokines; endothelial function; hyperlipoproteinemia; vascular biology

Indexed keywords

APOLIPOPROTEIN E; CYCLIN DEPENDENT KINASE INHIBITOR 1; FOCAL ADHESION KINASE 2; LYSOPHOSPHATIDYLCHOLINE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN P300; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSCRIPTION FACTOR ETS 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; AORTA; AORTA ATHEROSCLEROSIS; ARTICLE; ATTENUATION; CELL ACTIVATION; CONTROLLED STUDY; DIET THERAPY; ENDOTHELIUM CELL; GENE EXPRESSION; INFLAMMATION; INFLAMMATORY CELL; MALE; MEDIATOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION; TRANSCRIPTION REGULATION; WESTERN DIET;

EID: 85027950157     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATV.0000000000000005     Document Type: Erratum

References (25)

1. Libby P, Paul M, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-1143. (Pubitemid 34212626)
2. Lev, S. Moreno H, Martinez R, Canoll P, Peles E, Rudy B, Schlessinger J. Protein tyrosine kinase PYK2 involved in Ca(2)-induced regulation of ion channel and MAP kinase functions. Nature. 1995;376:737-745.
3. Tai LK, Okuda M, Abe J, and Berk BC. Fluid shear stress activates proline-rich tyrosine kinase via reactive oxygen species-dependent pathway. Arterioscler Thromb Vasc Biol. 2002;22:1790-1796. (Pubitemid 35315763)
4. Okigaki M, Davis C, Falasca M, Harroch S, Felsenfeld D, Sheetz MP, Schlessinger J. Pyk2 regulates multiple signaling events crucial for macrophage morphology and migration. Proc Natl Acad Sci USA. 2003;100: 10740-10745. (Pubitemid 37140098)
5. Matsui A, Okigaki M, Amano K, Adachi Y, Jin D, Takai S, Yamashita T, Kawashima S, Katsume A, Honshou S, Takahashi T, Matoba S, Matsubara H. Central role of calcium-dependent tyrosine kinase PYK2 in endothelial nitric oxide synthase-mediated angiogenic response and vascular function. Circulation. 2007;116:1041-1051. (Pubitemid 47329569)
6. Brizzi MF, Dentelli P, Pavan M, Rosso A, Gambino R, Camussi G, Pagano G, Pegoraro L. Diabetic LDL inhibits cell-cycle progression via STAT5B and p21waf. J Clin Invest. 2002;109:111-119. (Pubitemid 34052547)
7. Kunieda T, Minamino T, Nishi J, Tateno K, Oyama T, Katsuno T, Miyauchi H, Orimo M, Okada S, Takamura M, Nagai T, Kaneko S, Komuro I. Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway. Circulation. 2006;114:953-960. (Pubitemid 44337139)
8. Condorelli G, Aycock JK, Frati G, Napoli C. Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice. FASEB J. 2001; 15:2162-2170. (Pubitemid 32927933)
9. Urao N, Okigaki M, Yamada H, Aadachi Y, Matsuno K, Nomura T, Takahashi T, Tatsumi T, Matsubara H. Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia. Circ Res. 2006;98:1405-1413. (Pubitemid 43948065)
10. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases the role of oxidant stress. Circ Res. 2000;87:840-844.
11. Kougias P, Chai H, Lin PH, Lumsden AB, Qizhi YQ, Chen C. Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis. Med Sci Monit. 2006;12:RA5-RA16. (Pubitemid 43116665)
12. Frey RS, Ushio-Fukai M, Malik AB. NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology. Antioxid Redox Signal. 2009;11:791-810.
13. Zhang H, Park Y, Wu J, Chen X, Lee S, Yang J, Dellsperger KC, Zhang C. Role of TNF-in vascular dysfunction. Clin Sci. 2009;116:219-230.
14. Snowden AW, Anderson LA, Gill A, Neil D. Perkins ND. A novel transcriptional repression domain mediates p21WAF1/CIP1 induction of p300 transactivation. Mol Cell Biol. 2000;20:2676-2686. (Pubitemid 30183486)
15. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, Peacocke M, Campisi J. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA. 1995;92:9363-9367.
16. Nuntharatanapong N, Chen K, Sinhaseni P, Keaney JF Jr. EGF receptordependent JNK activation is involved in arsenite-induced p21Cip1/Waf1 upregulation and endothelial apoptosis. Am J Physiol Heart Circ Physiol. 2005;289:H99-H107. (Pubitemid 40934087)
17. Tokiwa G, Dikic I, Lev S, Schlessinger J. Activation of Pyk2 by stress signals and coupling with JNK signaling pathway. Science. 1996;273:792-794. (Pubitemid 26271523)
18. Zhan Y, Brown C, Maynard E, Anshelevich A, Ho IC, Oettgen P. Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. J. Clin. Invest. 2005;115:2508-2516. (Pubitemid 41266213)
19. Liu SY, Lu X, Choy S, Dembinski TC, Hatch GM, Angel A, Choy PC, Man RYK. Alteration of lysophosphatidylcholine content in low density lipoprotein after oxidative modification: relationship to endothelium dependent relaxation. Cardiovasc. Res. 1994;28:1476-1481. (Pubitemid 24318260)
20. Corr PB, Gross RW, Sobel BE Amphipathic metabolites and membrane dysfunction in ischemic myocardium. Circ Res. 1984;55:135-154. (Pubitemid 14032930)
21. Lee JY, Sohn KH, Rhee SH, Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem. 2001;276:16683-16689.
22. Podrez EA, Febbraio M, Sheibani N, Schmitt D, Silverstein R, Hajjar DP, Cohen P, Frazier WA, Hoff HF, Hazen SL. The macrophage scavenger receptor CD36 is the major pathway for LDL recognition following modification by monocyte-generated reactive nitrogen. J Clin Invest. 2000;105:1095-1108. (Pubitemid 30217694)
23. Anand AR, Bradley R, Ganju RK. LPS-induced MCP-1 expression in human microvascular endothelial cells is mediated by the tyrosine kinase, Pyk2 via the p38 MAPK/NF-B-dependent pathway. Mol Immunol. 2009;46:962-968.
24. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H and Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest. 2006;116:3015-3025. (Pubitemid 44684486)
25. Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer. 2009;9:400-414.